OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer MELVILLE, N.Y. & SOUTH SAN FRANCISCO, ...
Over the weekend, Bruce Perens, who was one of the original founders of the Open Source Initiative (OSI) but now currently serves as vice president of developer relations and policy for SourceLabs, ...
LONDON, Sept. 25, 2023 /PRNewswire/ -- MYCOM OSI, a leading independent provider of Network Assurance and Service Experience Assurance solutions to some of the world's largest Communications Service ...
Offers the benefits of predictive AI-based insights to automate network operations and maximize customer experience LONDON, Sept. 25, 2023 /PRNewswire/ -- MYCOM OSI, a leading independent provider of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results